Article

Blood, urine tests found to identify RP gene

A key marker in blood and urine has been found able to identify people who carry genetic mutations in a gene responsible for retinitis pigmentosa (RP) by researchers at Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine (UMMSM).

 

Miami-A key marker in blood and urine has been found able to identify people who carry genetic mutations in a gene responsible for retinitis pigmentosa (RP) by researchers at Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine (UMMSM).

“A simple urine test can tell who has the RP-causing mutations,” said Rong Wen, MD, PhD, professor of ophthalmology at Bascom Palmer. “Collecting urine is non-invasive and easy, especially from young children.”

Results of the research are published in the Journal of Lipid Research.

Scientists at UMMSM identified the first mutation in the gene, named DHDDS, in 2011.

 

For more articles in this issue of Ophthalmology Times eReport, click here.

 

 

To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.